Telomerase Activators From 20(27)-Octanor Via Biotransformation by the Fungal Endophytes
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Open Access Color
Green Open Access
Yes
OpenAIRE Downloads
OpenAIRE Views
Publicly Funded
No
Abstract
Cycloastragenol [20(R),24(S)-epoxy-3 beta,6 alpha,16 beta,25-tetrahydroxycycloartane] (CA), the principle sapogenol of many cycloartane-type glycosides found in Astragalus genus, is currently the only natural product in the anti-aging market as telomerase activator. Here, we report biotransformation of 20(27)-octanor-cycloastragenol (1), a thermal degradation product of CA, using Astragalus species originated endophytic fungi, viz. Penicillium roseopurpureum, Alternaria eureka, Neosartorya hiratsukae and Camarosporium laburnicola. Fifteen new biotransformation products (2-16) were isolated, and their structures were established by NMR and HRESIMS. Endophytic fungi were found to be capable of performing hydroxylation, oxidation, ring cleavage-methyl migration, dehydrogenation and Baeyer-Villiger type oxidation reactions on the starting compound (1), which would be difficult to achieve by conventional synthetic methods. In addition, the ability of the metabolites to increase telomerase activation in Hekn cells was evaluated, which showed from 1.08 to 12.4-fold activation compared to the control cells treated with DMSO. Among the compounds tested, 10, 11 and 12 were found to be the most potent in terms of telomerase activation with 12.40-, 7.89- and 5.43-fold increase, respectively (at 0.1, 2 and 10 nM concentrations, respectively).
Description
Keywords
Saponins, Cycloastragenol, Endophytic fungi, Fungal biotransformation, Telomerase activation, Potent metabolites, Sapogenins, Telomerase activation, Endophytic fungi, Fungi, Astragalus Plant, Saponins, Gene Expression Regulation, Enzymologic, Potent metabolites, Species Specificity, Cycloastragenol, Fungal biotransformation, Telomerase, Biotransformation
Fields of Science
0301 basic medicine, 0303 health sciences, 03 medical and health sciences
Citation
WoS Q
Scopus Q

OpenCitations Citation Count
17
Source
Volume
109
Issue
Start Page
End Page
PlumX Metrics
Citations
CrossRef : 20
Scopus : 21
PubMed : 10
Captures
Mendeley Readers : 23
Google Scholar™


